A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection

SARS-CoV-2 is a novel coronavirus responsible for the COVID-19 pandemic, in which acute respiratory infections are associated with high socio-economic burden. We applied high-content screening to a well-defined collection of 5632 compounds including 3488 that have undergone previous clinical investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellinger, Bernhard, Bojkova, Denisa, Zaliani, Andrea, Cinatl, Jindrich, Claussen, Carsten, Westhaus, Sandra, Keminer, Oliver, Reinshagen, Jeanette, Kuzikov, Maria, Wolf, Markus, Geisslinger, Gerd, Gribbon, Philip, Ciesek, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910569/
https://www.ncbi.nlm.nih.gov/pubmed/33637768
http://dx.doi.org/10.1038/s41597-021-00848-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910569/
https://www.ncbi.nlm.nih.gov/pubmed/33637768
http://dx.doi.org/10.1038/s41597-021-00848-4

Ejemplares similares